Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials (Q37060855)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 December 2015
edit
Language Label Description Also known as
English
Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials
scientific article published on 30 December 2015

    Statements

    Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials (English)
    Atsunori Kashiwagi
    Satoshi Yoshida
    Ichiro Nakamura
    Kenichi Kazuta
    Eiji Ueyama
    Hideyuki Takahashi
    Hayato Satomi
    Yoshinori Kosakai
    Kosei Kawamuki
    30 December 2015
    544-554

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit